We lead the synthetic biology industry, having developed and successfully commercialized the most Lab-to-Market™ ingredients. Our sustainable ingredients are used in thousands of top global brands, including our own family of consumer brands in Clean Beauty and Health markets.
EMERYVILLE, Calif., April 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that management will participate in a fireside chat at Cowen's 2nd Annual Consumer Platforms for the Next Generation Summit on Tuesday, April 6th at 9:30 am ET.
A live webcast of the presentation and a replay will be available on the Investor Relations section of the company's website at http://investors.amyris.com.
Amyris (Nasdaq: AMRS) is a science and technology leader in the research, development and production of sustainable ingredients for the Clean Health & Beauty and Flavors & Fragrances markets. Amyris uses an impressive array of exclusive technologies, including state-of-the-art machine learning, robotics and artificial intelligence. Our ingredients are included in over 3,000 products from the world's top brands, reaching more than 200 million consumers. Amyris is proud to own three consumer brands - all built around its No Compromise® promise of clean ingredients: Biossance® clean beauty skincare, Pipette® clean baby skincare and Purecane™, a zero-calorie sweetener naturally derived from sugarcane. For more information, please visit www.amyris.com.
Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and Purecane are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.
+1 (212) 600-1902
Paul Vincent, Vice President Strategic Finance and Treasury, Amyris, Inc.
+1 (510) 450-0761
Peter DeNardo, Investor Relations Consultant
+1 (510) 740-7481
Beth Bannerman, Chief Engagement & Sustainability Officer, Amyris, Inc.
+1 (510) 914-0022
SOURCE Amyris, Inc.